KX1-004

• CAT Number: I003872
• CAS Number: 518058-84-9
• Molecular Formula: C16H13FN2O2
• Molecular Weight: 284.29
• Purity: ≥95%
• Synonyms: 5-fluoro-N-(3-hydroxybenzyl)-1H-indole-2-carboxamide
• Target: Src
• Solubility: DMSO: ≥ 42 mg/mL
• Storage: Store at -20°C
• IUPAC Name: 5-fluoro-N-[(3-hydroxyphenyl)methyl]-1H-indole-2-carboxamide
• InChI: InChI=1S/C16H13FN2O2/c17-12-4-5-14-11(7-12)8-15(19-14)16(21)18-9-10-2-1-3-13(20)6-10/h1-8,19-20H,9H2,(H,18,21)
• InChIKey: TUIHIKXCMCXXJG-UHFFFAOYSA-N
• SMILES: C1=CC(=CC(=C1)O)CNC(=O)C2=CC3=C(N2)C=CC(=C3)F

KX1-004 (Cat No.: I003872) is an experimental small molecule compound explored for potential therapeutic applications in various disease models. While detailed public information remains limited, preliminary data suggest a mechanism involving modulation of specific cellular signaling pathways. Early research indicates it could provide benefits in conditions marked by inflammation or dysregulated immune responses. Ongoing investigations aim to clarify pharmacodynamics, optimize formulation, and ensure safety before advancing to clinical trials. If validated, KX1-004 may offer novel therapeutic options for patients with unmet medical needs.

Reference

[1]. Harris KC, et al. Prevention of noise-induced hearing loss with Src-PTK inhibitors. Hear Res. 2005 Oct;208(1-2):14-25.
[2]. Bielefeld EC, et al. A comparison of the protective effects of systemic administration of a pro-glutathione drug and a Src-PTK inhibitor against noise-induced hearing loss. Noise Health. 2005 Oct-Dec;7(29):24-30.